Daniel M. Purdham
Bayer (Canada)(CA)
Publications by Year
Research Areas
Adipose Tissue and Metabolism, Regulation of Appetite and Obesity, Adipokines, Inflammation, and Metabolic Diseases, Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → Rat heart is a site of leptin production and action(2004)170 cited
- → Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart(2008)115 cited
- → Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention(2015)111 cited
- → Leptin Induces Vascular Smooth Muscle Cell Hypertrophy through Angiotensin II- and Endothelin-1-Dependent Mechanisms and Mediates Stretch-Induced Hypertrophy(2005)108 cited
- → An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1(2006)102 cited
- → Leptin as a Cardiac Hypertrophic Factor: A Potential Target for Therapeutics(2007)69 cited
- → A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart(2008)63 cited
- → Identification of Fat Mass and Obesity Associated (FTO) Protein Expression in Cardiomyocytes: Regulation by Leptin and Its Contribution to Leptin-Induced Hypertrophy(2013)46 cited
- → NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling(2006)44 cited
- → Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment(2017)40 cited